François Dreyfus - Concepedia

Author

François Dreyfus

Also Known As

Dreyfus, François, F Dreyfus, F. Dreyfus, FRANÇOIS DREYFUS, Francois Dreyfus, François Dreyfus, François DREYFUS, François Dreyfus, François J. Dreyfus, M Alexis

232

Publications

18.2K

Citations

H-Index

Concepts

All Affiliations

Hôpital Cochin Assistance Publique – Hôpitaux de Paris Université Paris Cité Inserm Hôpital Avicenne

About

François Dreyfus is an author at Hôpital Cochin specializing in medicine, hematology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	33	49	4.3K
2	Health Sciences	14	16	647
3	Blood Transplantation	2	2	116
4	Allergy	1	1	268
5	Biostatistics	1	1	135

François Dreyfus

112

Publications

16.7K

Citations

H-Index

Page 1

	Year	Citations
Revised International Prognostic Scoring System for Myelodysplastic Syndromes Peter L. Greenberg, Heinz Tuechler, Julie Schanz, Blood	2012	3.1K
Mutation in <i>TET2</i> in Myeloid Cancers François Delhommeau, Sabrina Dupont, Véronique Della Valle, New England Journal of Medicine	2009	1.7K
High-Dose Therapy and Autologous Peripheral Blood Stem Cell Transplantation in Multiple Myeloma: Up-front or Rescue Treatment? Results of a Multicenter Sequential Randomized Clinical Trial Jean‐Paul Fermand, Philippe Ravaud, Sylvie Chevret, Blood	1998	539
Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia Raphaël Itzykson, Olivier Kosmider, Aline Renneville, Journal of Clinical Oncology	2013	537
Outcome of High-Risk Myelodysplastic Syndrome After Azacitidine Treatment Failure Thomas Prébet, Steven D. Gore, Benjamin Esterni, Journal of Clinical Oncology	2011	475
Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias Raphaël Itzykson, Olivier Kosmider, Thomas Cluzeau, Leukemia Hematological MalignancyMedicineMixed-phenotype Acute LeukemiaImmunologyHematology	2011	464
High-Dose Therapy and Autologous Blood Stem-Cell Transplantation Compared With Conventional Treatment in Myeloma Patients Aged 55 to 65 Years: Long-Term Results of a Randomized Control Trial From the Group Myelome-Autogreffe Jean‐Paul Fermand, Sandrine Katsahian, Marine Diviné, Journal of Clinical Oncology	2005	400
Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine Raphaël Itzykson, Sylvain Thépot, Bruno Quesnel, Blood	2010	383
Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experience Sophie Park, Sophie Grabar, Charikleia Kelaïdi, Blood	2007	328
Coronavirus 229E-Related Pneumonia in Immunocompromised Patients Frédéric Pène, A Merlat, Astrid Vabret, Clinical Infectious Diseases Viral EvolutionViral DiagnosticsTypical Crown-like ParticlesRespiratory DiseasesPathogenesis	2003	315

Page 1